United States· US:84778-082_3dbbfe4e-f9c5-67c8-e063-6294a90a4644
Esokalli Slimming microcrystalline patch
A medicinal product containing retatrutide, registered in United States by Guangzhou Yixin Cross-border E-commerce Co., Ltd..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- RETATRUTIDE
- Manufacturer
- Guangzhou Yixin Cross-border E-commerce Co., Ltd.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 5, 2026
Packs & prices · 8
- ndc1184778-082-01
- ndc1184778-082-02
- ndc1184778-082-03
- ndc1184778-082-04
- ndc1184778082011 PATCH in 1 BOX (84778-082-01) / 20 mg in 1 PATCH
- ndc1184778082022 PATCH in 1 BOX (84778-082-02) / 20 mg in 1 PATCH
- ndc1184778082034 PATCH in 1 BOX (84778-082-03) / 20 mg in 1 PATCH
- ndc1184778082048 PATCH in 1 BOX (84778-082-04) / 20 mg in 1 PATCH
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a9df4a14-4e7e-45f2-b88d-2a25c0bd2df6 GET /v1/drugs/a9df4a14-4e7e-45f2-b88d-2a25c0bd2df6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "20",
"substance": "RETATRUTIDE",
"productndc": "84778-082",
"dosage_form": "PATCH",
"dea_schedule": null,
"strength_unit": "mg/100mg",
"application_number": "505G(a)(3)",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about retatrutide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.